StonvexLoading…
StonvexStonvexStonvexCore line items from EQNR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $106.46B | $103.77B | $107.17B | $150.81B |
Operating Income | $25.35B | $30.93B | $35.77B | $78.81B |
Net Income | $5.06B | $8.83B | $11.90B | $28.74B |
EPS (Diluted) | $1.94 | $3.11 | $3.93 | $9.03 |
Total Assets | $131.73B | $131.14B | $143.58B | $158.02B |
Total Liabilities | $91.23B | $88.76B | $95.08B | $104.03B |
Cash & Equivalents | $5.04B | $5.90B | $8.07B | $9.45B |
Free Cash Flow OCF − CapEx | $5.98B | $7.29B | $18.68B | $26.38B |
Shares Outstanding | 2.56B | 2.79B | 3.00B | 3.18B |